Guaifenesin and Phenylephrine Hydrochloride
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
Guaifenesin and Phenylephrine Hydrochloride is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $0.07 to $0.07 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$0.07 – $0.07
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
RB Health (US) LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Expectorant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CHILD MUCINEX STUFFY NOSE-CHST | $0.0710 per ML | — |
Frequently Asked Questions
How many Guaifenesin and Phenylephrine Hydrochloride products are on the market?
The Guaifenesin and Phenylephrine Hydrochloride drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Guaifenesin and Phenylephrine Hydrochloride?
NADAC reference prices for Guaifenesin and Phenylephrine Hydrochloride range from $0.0710 to $0.0710 per ML.
Which manufacturers make Guaifenesin and Phenylephrine Hydrochloride?
1 manufacturer lists Guaifenesin and Phenylephrine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are RB Health (US) LLC (1).